Understood but things in biotech space move at a snails pace. Yes, volume is lacking but u have to remember this is on the stinky pinky and they need to upgrade to qb if they haven’t already
Everything I say is my educated opinion and is NOT investment advice
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.